A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />
Chapter 16: Clinic Management<br />
exposures or who were drug injec<strong>to</strong>rs. Screening<br />
for premalignant human papillomavirus (HPV)<br />
disease in men using anal Pap smears is potentially<br />
valuable, although it has not become a universal<br />
standard <strong>of</strong> practice.<br />
Clinics should also have a system in place <strong>to</strong> protect<br />
the safety <strong>of</strong> their employees in regard <strong>to</strong> occupational<br />
<strong>HIV</strong> exposure (See Chapter 10 as well as Suggested<br />
Resources below).<br />
On site<br />
Table 16-2. Comprehensive<br />
Ambula<strong>to</strong>ry <strong>HIV</strong> Program Standards<br />
<strong>of</strong> the New York State <strong>AIDS</strong> Institute<br />
Clinical services that must be provided by<br />
ambula<strong>to</strong>ry <strong>HIV</strong> programs<br />
• Age appropriate, confidential <strong>HIV</strong> counseling and testing<br />
• Initial and annual comprehensive medical evaluations,<br />
including substance abuse and mental health assessments<br />
• Cognitive function testing<br />
• Ongoing clinical <strong>HIV</strong> disease moni<strong>to</strong>ring<br />
• <strong>HIV</strong>-specific therapies and prophylactic treatments, including<br />
treatment education and adherence moni<strong>to</strong>ring<br />
• Routine gynecologic care and followup (including reproductive<br />
counseling, pelvic examinations, and Pap smears)<br />
• Routine family planning services<br />
• Case management<br />
• Patient health education, including risk reduction and nutrition<br />
counseling<br />
On site or via linkage<br />
• Access <strong>to</strong> consultations by specialists in infectious diseases<br />
• Core diagnostic and therapeutic services<br />
- labora<strong>to</strong>ry, including early diagnostic methods <strong>to</strong> establish<br />
the infection status <strong>of</strong> children<br />
- radiology, including MRI<br />
- pharmacy<br />
- dental services<br />
- mental health services, including clinical social work, clinical<br />
psychology, and psychiatry as clinically appropriate<br />
• Other primary care, specialty, and subspecialty services<br />
- obstetrics<br />
- pediatrics, adolescent medicine, and pediatric subspecialties<br />
- ophthalmology<br />
- derma<strong>to</strong>logy<br />
- outpatient surgery<br />
- clinical pharmacy<br />
- subspecialties <strong>of</strong> internal medicine, including<br />
gastroenterology, hema<strong>to</strong>logy, pulmonology, and oncology<br />
Source: New York State <strong>AIDS</strong> Institute. Comprehensive<br />
Ambula<strong>to</strong>ry <strong>HIV</strong> Program Standards. Part 490 <strong>of</strong> Title 10<br />
NYCRR. November 1994.<br />
What is different about providing <strong>HIV</strong> care<br />
compared <strong>with</strong> other types <strong>of</strong> medical care?<br />
<strong>HIV</strong> care is new; the epidemic was recognized in<br />
1981, and potent therapy became available in 1996.<br />
Therapeutic options are much improved, but there is<br />
little room for error. Drug resistance may occur rapidly<br />
and is irreversible. The ongoing development <strong>of</strong> new<br />
therapeutic agents is impressive, yet is not rapid enough<br />
<strong>to</strong> ensure future therapies <strong>to</strong> persons who received<br />
inappropriate prescriptions, or who did not receive the<br />
requisite education, support, and counseling <strong>to</strong> succeed<br />
<strong>with</strong> their therapy. With therapies that have been in<br />
use for less than 10 years, much is still unknown about<br />
long-term outcomes.<br />
Juxtaposed against the need for expertise in <strong>HIV</strong> care<br />
is the need <strong>to</strong> expand access. The only prerequisite<br />
<strong>to</strong> developing expertise in <strong>HIV</strong> care is commitment.<br />
A wide range <strong>of</strong> providers may be the <strong>HIV</strong> experts<br />
for their communities: midlevel practitioners and<br />
physicians, generalists and subspecialists. Providing<br />
infected persons <strong>with</strong> the <strong>to</strong>ols <strong>to</strong> succeed in their<br />
treatment and <strong>to</strong> avoid future <strong>HIV</strong> transmission may<br />
require stepwise behavior change. A persistent and<br />
nonjudgmental approach is most likely <strong>to</strong> be effective<br />
(for more on adherence see Chapter 7). Providers may<br />
have <strong>to</strong> change their own behaviors so they can be<br />
more effective in patient care.<br />
Most persons receiving <strong>HIV</strong> care reduce their<br />
transmission behaviors, lowering the risk <strong>of</strong> <strong>HIV</strong><br />
infection for others. Others do not change their<br />
behaviors, or do so only partially, or relapse. Providing<br />
prevention interventions in a clinic protects the public<br />
health. Clinic staff may know sex and drug using<br />
partners <strong>of</strong> patients, and find themselves <strong>with</strong> a duty <strong>to</strong><br />
warn those who may be unknowingly exposed. These<br />
issues will be familiar <strong>to</strong> those in tuberculosis and STD<br />
treatment settings; but for many these challenges are<br />
new (see Chapter 4 on <strong>HIV</strong> prevention and Chapter 13<br />
on substance abuse).<br />
<strong>HIV</strong>/<strong>AIDS</strong> is associated <strong>with</strong> discrimination and stigma<br />
because <strong>of</strong> its association <strong>with</strong> sexual behavior and<br />
<strong>with</strong> drug injection, and because <strong>HIV</strong> is incurable and<br />
may still be eventually fatal. His<strong>to</strong>rically, there has been<br />
discrimination because <strong>of</strong> fear <strong>of</strong> contagion based on<br />
misconceptions regarding transmission. Discrimination<br />
may still be encountered in families and communities<br />
experiencing <strong>HIV</strong> for the first time.<br />
16<br />
U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau<br />
135